Pancreatic cancer: New hopes after first line treatment

Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorith...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroldi, Francesca, Bertocchi, Paola, Savelli, Giordano, Rosso, Edoardo, Zaniboni, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027023/
https://www.ncbi.nlm.nih.gov/pubmed/27672426
http://dx.doi.org/10.4251/wjgo.v8.i9.682
_version_ 1782454171636596736
author Aroldi, Francesca
Bertocchi, Paola
Savelli, Giordano
Rosso, Edoardo
Zaniboni, Alberto
author_facet Aroldi, Francesca
Bertocchi, Paola
Savelli, Giordano
Rosso, Edoardo
Zaniboni, Alberto
author_sort Aroldi, Francesca
collection PubMed
description Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorithm.
format Online
Article
Text
id pubmed-5027023
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-50270232016-09-26 Pancreatic cancer: New hopes after first line treatment Aroldi, Francesca Bertocchi, Paola Savelli, Giordano Rosso, Edoardo Zaniboni, Alberto World J Gastrointest Oncol Minireviews Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorithm. Baishideng Publishing Group Inc 2016-09-15 2016-09-15 /pmc/articles/PMC5027023/ /pubmed/27672426 http://dx.doi.org/10.4251/wjgo.v8.i9.682 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Aroldi, Francesca
Bertocchi, Paola
Savelli, Giordano
Rosso, Edoardo
Zaniboni, Alberto
Pancreatic cancer: New hopes after first line treatment
title Pancreatic cancer: New hopes after first line treatment
title_full Pancreatic cancer: New hopes after first line treatment
title_fullStr Pancreatic cancer: New hopes after first line treatment
title_full_unstemmed Pancreatic cancer: New hopes after first line treatment
title_short Pancreatic cancer: New hopes after first line treatment
title_sort pancreatic cancer: new hopes after first line treatment
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027023/
https://www.ncbi.nlm.nih.gov/pubmed/27672426
http://dx.doi.org/10.4251/wjgo.v8.i9.682
work_keys_str_mv AT aroldifrancesca pancreaticcancernewhopesafterfirstlinetreatment
AT bertocchipaola pancreaticcancernewhopesafterfirstlinetreatment
AT savelligiordano pancreaticcancernewhopesafterfirstlinetreatment
AT rossoedoardo pancreaticcancernewhopesafterfirstlinetreatment
AT zanibonialberto pancreaticcancernewhopesafterfirstlinetreatment

Ejemplares similares